期刊文献+

趋化因子受体3 RNA干扰慢病毒载体的构建及对嗜酸粒细胞作用的初步研究 被引量:2

Construction and identification of mouse eosinophils CCR3 gene RNA interference lentiviral vector
原文传递
导出
摘要 目的构建趋化因子受体3(chemokine receptor3,CCR3)基因RNA干扰(RNA interference,RNAi)慢病毒表达载体,了解其对嗜酸粒细胞的作用。方法针对小鼠CCR3基因序列,设计出RNAi的靶序列,退火形成双链DNA,与经MluI、SacI、EcoRI、HindIll、BamHI和XhoI进行酶切后的pLVX—shRNA2一m载体连接产生短发夹RNA(shoa hairpin RNA,shRNA)慢病毒载体。应用shRNA慢病毒载体转染293T细胞及嗜酸粒细胞,测定病毒滴度,实时定量聚合酶链反应检测嗜酸粒细胞中CCR3基因mRNA的表达情况。结果成功构建了shRNA—mCCR3慢病毒载体,经测序与设计合成的靶向链完全一致。荧光显微镜下观察293T细胞感染效率大于90%,病毒滴度为4×10。TU/ml;对嗜酸粒细胞CCR3基因沉默效率为86.7%。结论成功构建CCR3基因RNAi慢病毒表达载体,为后续感染嗜酸粒细胞,探索其在变应性鼻炎发生和发展中的作用奠定了基础。 Objective Through construction of a lentiviral expression vector of chemokine receptor 3 (CCR3)RNA interference (RNAi) of mouse, to further study the function of CCR3 gene on eosinophils. Methods Focused on the CCR3 gene sequences, RNAi target sequences were designed, then the target sequences of Oligo DNA were synthesized and annealed to double stranded DNA, which was subsequently connected to pLVX-shRNA2-m vector digested by MluI, Sac I , EcoR I , Hind lll, BamH I and Xho I , short hairpin RNA lentiviral vectors were constructed. Short hairpin RNA lentiviral vectors were constructed. 293T cells and eosinophils were transfeeted by shRNA lentiviral vector, and virus titer was determined. The expression of the CCR3 gene in eosinophils was identified by quantitative-PCR. Results The lentiviral vector of shRNA-mCCR3-oligonucleotide chain was inserted correctly. Infection efficiency of 293T cells observed under fluorescence microscope was more than 90%, the virus titer was 4 x 108TU/ml. CCR3 interference rate was 86. 7%. Conclusion A lentiviral vector of CCR3-gene RNAi was constructed successfully by the genetic engineering technology, and it provides a condition for further research in vitro and vivo.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2013年第4期316-321,共6页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家自然科学基金(81060084) 江西省自然科学基金(2010GZY0251) 江西省卫生厅科技计划(20131059)
关键词 RNA干扰 受体 CCR3 慢病毒属 嗜酸细胞 RNA interference Receptors, CCR3 Lentivirus Eosinophils
  • 相关文献

参考文献15

  • 1张罗,韩德民.重视变应性鼻炎研究[J].中华耳鼻咽喉头颈外科杂志,2010,45(6):441-443. 被引量:6
  • 2Munitz A, Bachelet I, Eliashar R, et al. CD48 Is an Allergen and IL3-Induced Activation Molecule on Eosinophils. J Immunol,2006, 177(1): 77-83.
  • 3Melo RC, Spencer LA, Dvorak AM, et al. Mechanisms of eosinophil secretion : large vesiculotubular carriers mediate transport and release of granule-derived eytokines and other proteins. J. Leukoc. Biol, 2008,83 (2) :229-236.
  • 4Shi HZ. Eosinophils function as antigen-presenting cells. J. Leukoe. Biol, 2004, 76(3): 520-527.
  • 5Wang HB, Ghiran I, Matthaei K, et al. AirwayEosinophils : Allergic Inflammation Recruited Professional An.tigen-Presenting Cells. J Immunol. 2007, 179( 1 ) : 7585-7592.
  • 6罗鸿,陶泽璋,孔维佳.变应性鼻炎造血机制的调控与嗜酸性粒细胞的产生[J].国际耳鼻咽喉头颈外科杂志,2009,33(2):67-70. 被引量:8
  • 7Fulkerson PC, Fischetti CA, McBride ML, et al. A central regulatory role for eosinophils and the eotaxin CCR3 axis in chronic experimental allergic airway inflammation. Proc Natl Acad Sci U S A, 2006,133(44) : 16418-16423.
  • 8Lee CC, Chiang BL. RNA interference: new therapeutics in allergic diseases. Curr Gene Ther, 2008, 8(4) : 236-246.
  • 9李曙芳,刘田福.RNA干扰技术的应用新进展[J].中国实验动物学报,2009,17(1):76-79. 被引量:4
  • 10Suzuki M, Zheng X, Zhartg X, et al. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol, 2008, 180(12) : 8461-8469.

二级参考文献71

  • 1Roel NUSSE.Wnt signaling in disease and in development[J].Cell Research,2005,15(1):28-32. 被引量:85
  • 2张辉,张大良,张红萍,陈颖洁,郭成浩.变应性鼻炎患者外周血CD34^+和白介素5及嗜酸粒细胞的检测[J].中华耳鼻咽喉头颈外科杂志,2005,40(7):541-542. 被引量:12
  • 3李伟,孔维佳,乐建新.RNA干扰载体活体内耳转染的可行性[J].临床耳鼻咽喉科杂志,2006,20(22):1024-1026. 被引量:1
  • 4Boisvert ME, Simard MJ. RNAi pathway in C. elegans: the argonautes and collaborators[ J]. Curr Top Microbiol Immunol, 2008. 320:21 - 36.
  • 5Yokota T. Gene therapy of ALS with short interfering RNA[J]. Brain Nerve, 2007. 59(10): 1187-1194.
  • 6Yokota T, Iijima. S, Kubodera. T, et al. Efficient regulation of viral replication by siRNA in a non-haman primate surrogate model for hepatitis C[J]. Biochem Biophys Res Commun, 2007, 361(2): 294 - 300.
  • 7Pan Q, Liu B, Liu J, et al. Synergistic aatitumor activity of XIAP- shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC[J]. Acta Oncol, 2007:1 - 10.
  • 8Wang Z, Li L. Adenovirus-mediated interference against collagen- specific molecular chaperone 47-kDa heat shock protein suppresses sear formation on mouse wounds [ J ]. Cell Biol Int, 2008, 32 ( 5 ) : 484 - 483.
  • 9Maehida Y, Okada T, Kurosawa M, et al. rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse[J]. Biochem Biophys Res Commun, 2006. 343(1):190- 197.
  • 10Chen CC, Ko TM, Ma H I, et al. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8- delivered short hairpin RNA[J]. Gene Ther, 2007. 14(1) :11 - 19.

共引文献17

同被引文献15

  • 1Li C,Rossomando A,Wu SL,et al. Comparability analysis of anti-CD20 commercial(rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches [J]. MAbs,2013,5(4) :565-575.
  • 2Vengut-Climent E,Terrazas M, Lucas R, et al. Synthesis, RNAi activity and nuclease-resistant properties of apolarcarbohydrates siRNA conjugates[J]. Bioorg Med Chem Lett,2013,23(14) :4048-4051.
  • 3Ambrosini G, Adida C, Ahieri DC. A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma[J]. Nat Med,1997,3(8) :917-921.
  • 4Kunze D, Erdmann K, Froehner M, et al. Enhanced inhibi- tion of bladder cancer cell growth by simultaneous knock- down of antiapoptotic Bcl-xL and survivin in combination with chemotherapy[J]. Int J Mol Sci,2013,14(6) : 12297- 12312.
  • 5Sarti M,Pinton S, Limoni C, et al. Differential expression of testin and survivin in breast cancer subtypes[J]. Oncol Rep, 2013,30(2) : 824-832.
  • 6Portanova P, Notaro A, Pellerito O, et a[. Notch inhibition restores TRAIL-mediated apoptosis via APl-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA- MB-231 breast cancer eells[J]. Int J Oncol,2013,43(1) : 121-130.
  • 7Turksma AW, Bontkes H J, Ruizendaal J J, et al, Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients[J]. J Transl Med,2013,20(11) :152.
  • 8Li C,Ye H. Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its meehanism[J]. Eur J Gynaecol Oncol, 2013, 34 (2) : 142-147.
  • 9李曙芳,刘田福.RNA干扰技术的应用新进展[J].中国实验动物学报,2009,17(1):76-79. 被引量:4
  • 10边中启,刘霜,刘明秋,肖安,焦晔,严维耀,郑兆鑫,刘雪松(编辑).靶向preC/C基因特异性RNA干扰对乙型肝炎病毒在肝癌细胞系中复制与表达的影响[J].中华医学杂志,2012,92(11):768-772. 被引量:3

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部